64 results
6-K
EX-99.1
BLU
Bellus Health Inc
28 Jun 23
GSK completes acquisition of BELLUS Health
11:05am
of BELLUS is highly synergistic with GSK’s expertise in respiratory medicines and is further supported by GSK’s leading R&D, manufacturing
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
, United States
Executive Vice President, Head of R&D and Chief Medical Officer of CSL Behring (10)
Director
NIL
Joseph Rus (5), (7)
Toronto
6-K
EX-99.2
BLU
Bellus Health Inc
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
external R&D expenses incurred for the development of camlipixant, mainly for activities in relation to our CALM Phase 3 clinical program, which
6-K
EX-99.1
BLU
Bellus Health Inc
12 May 23
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
4:02pm
increase. The increase is primarily attributable to higher external R&D spend incurred for the development of camlipixant, mainly for activities
6-K
EX-99.1
BLU
Bellus Health Inc
18 Apr 23
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
6:02am
and is further supported by GSK’s leading R&D, manufacturing, and commercialisation capabilities.
Following the anticipated regulatory approval and launch
6-K
EX-99.2
ha7sv8 jqjuem
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
EX-99.1
aqn4cy3gbmclsdz
29 Mar 23
Current report (foreign)
5:26pm
6-K
EX-99.2
jscn23byq1oc0zyyt4
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
6-K
EX-99.1
miz2s hfb1z46
14 Nov 22
BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights
4:03pm
6-K
EX-99.2
eg9q6
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
6-K
EX-99.1
6a53qwdh3
10 Aug 22
BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights
4:31pm
6-K
EX-99.1
4fl3ins kmyyu0xfd
11 May 22
BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights
5:23pm
6-K
EX-99.2
c3dh0mo
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
EX-99.2
nlj3d692
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
40-F
EX-99.1
vxeznq
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.2
vfa gj2nja3n5cmnwsv
9 Apr 21
Notice of Annual Meeting of Shareholders
12:00am
6-K
EX-99.1
vonep1d w2lhv53
8 Apr 21
Bellus HEALTH 2020 ANNUAL REPORT
10:16am
40-F
EX-99.3
ws5e8 pnsm1v43t8
25 Feb 21
Annual report (Canada)
4:58pm
40-F
EX-99.1
ql07e5rsze
25 Feb 21
Annual report (Canada)
4:58pm
6-K
EX-99.1
oarxvj0tiepm4joybf2
7 Dec 20
Bellus Health Inc. 6-K
7:01am